Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Suddath

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of the American Academy of Psychiatry and the Law|January 6, 2006
Violent fantasy, dangerousness, and the duty to warn and protectDavid M Gellerman, Robert Suddath
Expert Review of Neurotherapeutics|July 20, 2005
Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorderJames J McGough, Caroly S Pataki, Robert Suddath
Journal of Child and Adolescent Psychopharmacology|October 22, 2008
Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndromeJames T McCracken, Robert Suddath, Susanna Chang, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 4, 2008
Pediatric emergency department suicidal patients: two-site evaluation of suicide ideators, single attempters, and repeat attemptersJoan Rosenbaum Asarnow, Larry J Baraff, Michele Berk, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2012
An emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatmentJoan Rosenbaum Asarnow, Larry J Baraff, Michele Berk, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 28, 2009
A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorderJames J McGough, James T McCracken, Sandra K Loo, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 3, 2009
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment responseJoan Rosenbaum Asarnow, Graham Emslie, Greg Clarke, et al.
JAMA|March 4, 2008
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trialDavid Brent, Graham Emslie, Greg Clarke, et al.
The Journal of Clinical Psychiatry|September 27, 2019
CorrectionBenedetto Vitiello, Graham Emslie, Gregory Clarke, et al.
The American Journal of Psychiatry|February 19, 2009
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) studyDavid A Brent, Graham J Emslie, Greg N Clarke, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of the American Academy of Psychiatry and the Law|January 6, 2006
Violent fantasy, dangerousness, and the duty to warn and protectDavid M Gellerman, Robert Suddath
Expert Review of Neurotherapeutics|July 20, 2005
Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorderJames J McGough, Caroly S Pataki, Robert Suddath
Journal of Child and Adolescent Psychopharmacology|October 22, 2008
Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndromeJames T McCracken, Robert Suddath, Susanna Chang, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 4, 2008
Pediatric emergency department suicidal patients: two-site evaluation of suicide ideators, single attempters, and repeat attemptersJoan Rosenbaum Asarnow, Larry J Baraff, Michele Berk, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2012
An emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatmentJoan Rosenbaum Asarnow, Larry J Baraff, Michele Berk, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 28, 2009
A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorderJames J McGough, James T McCracken, Sandra K Loo, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 3, 2009
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment responseJoan Rosenbaum Asarnow, Graham Emslie, Greg Clarke, et al.
JAMA|March 4, 2008
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trialDavid Brent, Graham Emslie, Greg Clarke, et al.
The Journal of Clinical Psychiatry|September 27, 2019
CorrectionBenedetto Vitiello, Graham Emslie, Gregory Clarke, et al.
The American Journal of Psychiatry|February 19, 2009
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) studyDavid A Brent, Graham J Emslie, Greg N Clarke, et al.
Pageof 2